Home
Market Capitalization of Eiko Lifesciences Ltd

Eiko Lifesciences Ltd
NSE: EIKOLIFESCIENCE
Market Cap
Key Highlights
- The Market Cap of Eiko Lifesciences Ltd is ₹ 68.97 crore as of 21 Feb 25 .
- The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 55.4 as of 21 Feb 15:30 .
- The Dividend Payouts of Eiko Lifesciences Ltd is ₹ 0.25 as of Sep 20, 2017 .

Eiko Lifesciences Ltd
NSE: EIKOLIFESCIENCE
Share Price
Market Price of Eiko Lifesciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 55.4 |
20 Feb 2025 | 54.77 |
19 Feb 2025 | 54.49 |
18 Feb 2025 | 51.1 |
17 Feb 2025 | 50.05 |
14 Feb 2025 | 52.93 |
13 Feb 2025 | 51.51 |
12 Feb 2025 | 49.47 |
11 Feb 2025 | 48.47 |
10 Feb 2025 | 54.32 |
SWOT Analysis Of Eiko Lifesciences Ltd
BlinkX Score for Eiko Lifesciences Ltd
Asset Value vs Market Value of Eiko Lifesciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Eiko Lifesciences Ltd
Historical P/E Ratio of Eiko Lifesciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Eiko Lifesciences Ltd
Historical Revenue of Eiko Lifesciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Eiko Lifesciences Ltd
Historical EBITDA of Eiko Lifesciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Eiko Lifesciences Ltd
Historical Net Profit of Eiko Lifesciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Eiko Lifesciences Ltd

Eiko Lifesciences Ltd
NSE: EIKOLIFESCIENCE
DIVIDENDPAYOUT
About Eiko Lifesciences Ltd
- Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
- Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
- Earlier, the Company engaged in sale and purchase of shares and securities.
- At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.
Eiko Lifesciences Ltd News Hub
Eiko Lifesciences standalone net profit rises 337.50% in the June 2024 quarter
Net profit of Eiko Lifesciences rose 337.50% to Rs 0.35 crore in the quarter ended June 2024 as agai
Read more
14 Aug 24
Eiko Lifesciences to discuss results
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 13 August 2024. Po
Read more
05 Aug 24
Eiko Lifesciences to convene AGM
Eiko Lifesciences announced that the 47th Annual General Meeting (AGM) of the company will be held o
Read more
18 Sept 24
Eiko Lifesciences to discuss results
Eiko Lifesciences will hold a meeting of the Board of Directors of the Company on 19 October 2024. P
Read more
14 Oct 24